Proposed Collection; 60-Day Comment Request; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) (NCI), 22211-22212 [2015-09090]

Download as PDF Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices Dated: April 14, 2015. Genevieve deAlmeida, Project Clearance Liaison, National Institute on Drug Abuse. [FR Doc. 2015–09089 Filed 4–20–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences Notice of Closed Meetings tkelley on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel, Child Health and the Environment Review Committee. Date: May 12–14, 2015. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Crystal City Marriott at Reagan National Airport, 1999 Jefferson David Highway, Arlington, VA 22202. Contact Person: Linda K Bass, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, Nat’l Institute Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, (919) 541– 1307. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel, Cell Differentiation Assays. Date: May 15, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Chapel Hill, One Europa Drive, Chapel Hill, NC 27517. Contact Person: Sally Eckert-Tilotta, Ph.D., Scientific Review Officer, Nat. Institute of Environmental Health Sciences, Office of Program Operations, Scientific Review Branch, P.O. Box 12233, Research Triangle VerDate Sep<11>2014 18:07 Apr 20, 2015 Jkt 235001 Park, NC 27709, (919) 541–1446 eckertt1@ niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: April 15, 2015. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–09061 Filed 4–20–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; 60-Day Comment Request; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) (NCI) In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute (NCI), National Institutes of Health (NIH), will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 22211 technological collection techniques or other forms of information technology. To Submit Comments and for Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Kelly Yu, Ph.D., Division of Cancer Prevention, 9609 Medical Center Drive, Room 5E230, Rockville, MD 20850 or call non-tollfree number 240–276–7041 or Email your request, including your address to: yuke@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), 0925–0407, Extension, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: This is a request for a revision of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). This trial was designed to determine if cancer screening for prostate, lung, colorectal, and ovarian cancer can reduce mortality from these cancers which caused an estimated 253,320 deaths in the U.S. in 2014. The design is a two-armed randomized trial of men and women aged 55 to 74 at entry. OMB first approved this study in 1993 and has approved it every 3 years since then. Recruitment was completed in 2001, baseline cancer screening was completed in 2006, and data collection continues on the current cohort of 77,281 participants who are actively being followed. The additional followup will provide data that will clarify further the long term effects of the screening on cancer incidence and mortality for the four targeted cancers. Further, demographic and risk factor information may be used to analyze the differential effectiveness of cancer screening in high versus low risk individuals. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 26,320. E:\FR\FM\21APN1.SGM 21APN1 22212 Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Form name Type of respondents Annual Study Update(ASU) Form .... ASU Telephone Script ...................... Authorization to Release Medical Records. Health Status Questionnaire (Female) (HSQ). Health Status Questionnaire (Male) (HSQ). Medication Use Questionnaire (MUQ). Participants who complete the ASU Non Responders to the ASU ........... Participants who report new cancers Female participants who complete the HSQ. Male participants who complete the HSQ. Participants who complete the MUQ Dated: April 7, 2015. Karla Bailey, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2015–09090 Filed 4–20–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meetings tkelley on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Age-Related Hearing Loss. Date: May 20, 2015. Time: 3:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, Suite 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Elaine Lewis, Ph.D., Scientific Review Branch, National Institute on Aging, Gateway Building, Suite 2C212, MSC–9205, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–402–7707, elainelewis@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel; Alzheimer Pathogenesis. Date: June 18, 2015. VerDate Sep<11>2014 19:30 Apr 20, 2015 Jkt 235001 Number of responses per respondent Average time per response (minutes/hour) Annual burden hours 77,281 3,091 2,700 1 1 1 5/60 5/60 3/60 6,440 258 135 960 1 5/60 87 1,040 1 5/60 80 77,281 1 15/60 19,320 Number of respondents Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, Suite 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Jeannette L. Johnson, Ph.D., National Institutes on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301–402– 7705, JOHNSONJ9@NIA.NIH.GOV. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Agenda: To review and evaluate grant applications. Place: National Library of Medicine, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Zoe E. Huang, MD, Scientific Review Officer, Extramural Programs, National Library of Medicine, NIH, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20892–7968, 301–594–4937, huangz@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS) Dated: April 15, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. Dated: April 15, 2015. Michelle Trout, Program Analyst, Office of the Federal Advisory Committee Policy. [FR Doc. 2015–09062 Filed 4–20–15; 8:45 am] [FR Doc. 2015–09056 Filed 4–20–15; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Library of Medicine; Notice of Closed Meeting Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Library of Medicine Special Emphasis Panel; Scholarly Works G13. Date: June 26, 2015. Time: 9:00 a.m. to 6:00 p.m. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Functions and Development of the Mirror Neuron System. E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 80, Number 76 (Tuesday, April 21, 2015)]
[Notices]
[Pages 22211-22212]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-09090]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request; Prostate, Lung, 
Colorectal and Ovarian Cancer Screening Trial (PLCO) (NCI)

SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of 
the Paperwork Reduction Act of 1995, for opportunity for public comment 
on proposed data collection projects, the National Cancer Institute 
(NCI), National Institutes of Health (NIH), will publish periodic 
summaries of proposed projects to be submitted to the Office of 
Management and Budget (OMB) for review and approval.
    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) Ways to minimize the burden of the 
collection of information on those who are to respond, including the 
use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.
    To Submit Comments and for Further Information: To obtain a copy of 
the data collection plans and instruments, submit comments in writing, 
or request more information on the proposed project, contact: Kelly Yu, 
Ph.D., Division of Cancer Prevention, 9609 Medical Center Drive, Room 
5E230, Rockville, MD 20850 or call non-toll-free number 240-276-7041 or 
Email your request, including your address to: yuke@mail.nih.gov. 
Formal requests for additional plans and instruments must be requested 
in writing.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: Prostate, Lung, Colorectal, and Ovarian Cancer 
Screening Trial (PLCO), 0925-0407, Extension, National Cancer Institute 
(NCI), National Institutes of Health (NIH).
    Need and Use of Information Collection: This is a request for a 
revision of the Prostate, Lung, Colorectal and Ovarian Cancer Screening 
Trial (PLCO). This trial was designed to determine if cancer screening 
for prostate, lung, colorectal, and ovarian cancer can reduce mortality 
from these cancers which caused an estimated 253,320 deaths in the U.S. 
in 2014. The design is a two-armed randomized trial of men and women 
aged 55 to 74 at entry. OMB first approved this study in 1993 and has 
approved it every 3 years since then. Recruitment was completed in 
2001, baseline cancer screening was completed in 2006, and data 
collection continues on the current cohort of 77,281 participants who 
are actively being followed. The additional follow-up will provide data 
that will clarify further the long term effects of the screening on 
cancer incidence and mortality for the four targeted cancers. Further, 
demographic and risk factor information may be used to analyze the 
differential effectiveness of cancer screening in high versus low risk 
individuals.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 26,320.

[[Page 22212]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
           Form name                 Type of         Number of     responses per   per response    Annual burden
                                   respondents      respondents     respondent    (minutes/hour)       hours
----------------------------------------------------------------------------------------------------------------
Annual Study Update(ASU) Form.  Participants who          77,281               1            5/60           6,440
                                 complete the
                                 ASU.
ASU Telephone Script..........  Non Responders             3,091               1            5/60             258
                                 to the ASU.
Authorization to Release        Participants who           2,700               1            3/60             135
 Medical Records.                report new
                                 cancers.
Health Status Questionnaire     Female                       960               1            5/60              87
 (Female) (HSQ).                 participants
                                 who complete
                                 the HSQ.
Health Status Questionnaire     Male                       1,040               1            5/60              80
 (Male) (HSQ).                   participants
                                 who complete
                                 the HSQ.
Medication Use Questionnaire    Participants who          77,281               1           15/60          19,320
 (MUQ).                          complete the
                                 MUQ.
----------------------------------------------------------------------------------------------------------------


    Dated: April 7, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2015-09090 Filed 4-20-15; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.